{
  "id": "matrixMatch_insulin_management_v2026_1771708017286_75",
  "type": "matrixMatch",
  "matrixType": "multipleChoice",
  "stem": "The nurse is caring for a client with diabetes mellitus who is prescribed various types of insulin. Based on the provided information, match each insulin type to its expected peak time.",
  "itemContext": {
    "tabs": [
      {
        "id": "sbar",
        "title": "Nurses' Notes",
        "content": "**S:** Mr. Jones, a 62-year-old male with a history of type 1 diabetes, reports feeling shaky and sweaty this morning. He took 20 units of insulin lispro at 07:00 before breakfast. \n**B:** Mr. Jones has a 20-year history of type 1 diabetes, managed with insulin. He reports good adherence to his insulin regimen, but occasionally experiences hypoglycemia. His last HbA1c was 7.8% three months ago.\n**A:** At 09:00, Mr. Jones's blood glucose is 55 mg/dL. He is alert and oriented, but diaphoretic and slightly anxious. Vital signs are stable but trending towards tachycardia. We administered 15 grams of oral glucose and rechecked his blood glucose in 15 minutes.\n**R:** Blood glucose is now 85 mg/dL at 09:15. Continue to monitor blood glucose levels every hour for the next few hours. Educate the patient on recognizing hypoglycemia symptoms and appropriate actions. Discuss adjusting insulin dosage with the provider if hypoglycemia continues. Call provider if blood glucose is less than 70 mg/dL at next check. Recommend patient eat a complex carbohydrate snack to prevent rebound hypoglycemia. Ensure patient understands the importance of consistent meal times in relationship to insulin administration. Scheduled for discharge at 17:00. Document patient education."
      },
      {
        "id": "vitals",
        "title": "Vital Signs",
        "content": "07:00: BP 130/80, HR 78, RR 16, Temp 98.6째F, SpO2 98%, Glucose 180 mg/dL\n09:00: BP 120/70, HR 102, RR 18, Temp 98.2째F, SpO2 99%, Glucose 55 mg/dL\n09:15: BP 125/75, HR 90, RR 17, Temp 98.4째F, SpO2 99%, Glucose 85 mg/dL\n10:00: BP 135/85, HR 82, RR 16, Temp 98.6째F, SpO2 98%, Glucose 120 mg/dL"
      },
      {
        "id": "labs",
        "title": "Lab Results",
        "content": "Glucose (Fasting): 70-100 mg/dL\n- 07:00: 180 mg/dL\n- 09:00: 55 mg/dL\n- 09:15: 85 mg/dL\n- 10:00: 120 mg/dL\nHbA1c: <5.7% (Normal), 5.7-6.4% (Prediabetes), >=6.5% (Diabetes)\n- 3 months ago: 7.8%"
      },
      {
        "id": "exam",
        "title": "Physical Exam",
        "content": "07:00: Alert and oriented x3, skin warm and dry, no visible signs of distress.\n09:00: Alert and oriented x3, skin cool and clammy, diaphoretic, slight tremor noted in hands. Patient reports feeling shaky and anxious. Lung sounds clear bilaterally. Heart rate regular, no murmurs noted. \n09:15: Alert and oriented x3, skin slightly moist, less diaphoretic, tremor resolving. Patient reports feeling better. Lung sounds clear bilaterally. Heart rate regular, no murmurs noted.\n10:00: Alert and oriented x3, skin warm and dry, no visible signs of distress. Patient reports feeling well."
      },
      {
        "id": "orders",
        "title": "Care Plan",
        "content": "- Monitor blood glucose levels before meals and at bedtime.\n- Administer insulin as prescribed based on blood glucose levels.\n- Educate patient on signs and symptoms of hypoglycemia and hyperglycemia.\n- Provide patient with a carbohydrate snack if blood glucose is < 70 mg/dL.\n- Review insulin administration technique with the patient."
      },
      {
        "id": "mar",
        "title": "MAR",
        "content": "07:00: Insulin lispro 20 units subcutaneous\n07:00: Regular Insulin 5 units subcutaneous\n08:00: Insulin glargine 30 units subcutaneous"
      }
    ]
  },
  "rows": [
    {
      "id": "r1",
      "text": "Insulin lispro"
    },
    {
      "id": "r2",
      "text": "Regular insulin"
    },
    {
      "id": "r3",
      "text": "Insulin glargine"
    }
  ],
  "columns": [
    {
      "id": "c1",
      "text": "0.5 - 1.5 hours"
    },
    {
      "id": "c2",
      "text": "2 - 4 hours"
    },
    {
      "id": "c3",
      "text": "No pronounced peak"
    }
  ],
  "correctAnswers": {
    "r1": [
      "c1"
    ],
    "r2": [
      "c2"
    ],
    "r3": [
      "c3"
    ]
  },
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "analyzeCues",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "Insulin Management"
    ]
  },
  "rationale": {
    "correct": "Insulin lispro is a rapid-acting insulin analog with a peak effect occurring in 0.5-1.5 hours. Regular insulin is a short-acting insulin with a peak effect occurring in 2-4 hours. Insulin glargine is a long-acting insulin analog that provides a relatively constant level of insulin over 24 hours, therefore, it has no pronounced peak.",
    "incorrect": "Selecting incorrect peak times for each insulin type indicates a misunderstanding of their pharmacokinetic profiles, which are crucial for safe and effective diabetes management. Incorrect matching can lead to inappropriate insulin administration, resulting in hypo- or hyperglycemia.",
    "answerBreakdown": [
      {
        "id": "r1",
        "text": "Insulin lispro",
        "rationale": "Insulin lispro is a rapid-acting insulin. The nurse's note indicates that the patient's blood glucose dropped rapidly after administration of lispro, suggesting the peak effect occurred within 0.5 - 1.5 hours."
      },
      {
        "id": "r2",
        "text": "Regular insulin",
        "rationale": "Regular insulin is a short-acting insulin. Its peak effect typically occurs within 2 - 4 hours."
      },
      {
        "id": "r3",
        "text": "Insulin glargine",
        "rationale": "Insulin glargine is a long-acting insulin with a duration of action up to 24 hours. It is designed to provide a basal level of insulin with no pronounced peak, to mimic the body's natural insulin secretion."
      }
    ],
    "clinicalPearls": [
      "Always consider the onset, peak, and duration of insulin when planning meals and activities for clients with diabetes.",
      "Hypoglycemia is more likely to occur during the peak action time of insulin. Monitor for symptoms and educate patients about prevention and treatment.",
      "Long-acting insulins like glargine provide a basal level of insulin and should not be mixed with other insulins."
    ],
    "questionTrap": {
      "trap": "Students may confuse the peak times of different insulins, especially rapid-acting and short-acting insulins.",
      "howToOvercome": "Use mnemonics to memorize the onset, peak, and duration of different insulin types. Regularly review insulin pharmacokinetics and practice clinical scenarios."
    },
    "mnemonic": {
      "title": "Peak Times Mnemonic",
      "expansion": "Rapid Lispro = 'Half-hour Peak Pro', Regular = 'Two to Four, Door to Door', Glargine = 'Large and Long, No Peak Song'"
    }
  },
  "scoring": {
    "method": "polytomous",
    "maxPoints": 3
  },
  "sentinelStatus": "healed_v2026_v9"
}